Search results
Patients you can help, we can reach. With our comprehensive portfolio of end-to-end pharmaceutical commercialization solutions, Cencora empowers patient-centered care all over the world. 6.7 million. products shipped daily. 1,300. worldwide locations. 50+. countries. See what we do.
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2] Services. They provide drug distribution and consulting related to medical business operations and patient services.
We’re advancing pharmaceutical care as Cencora. In August 2023, we united all the companies and services of AmerisourceBergen in our common purpose to create healthier futures. We’re now accelerating positive outcomes for our customers and their patients under our new name, Cencora. Learn more about who we are.
Cencora navigates logistics complexities with care, from customs requirements and regulatory contingencies to servicing countries with limited infrastructure. We ensure trials, gene therapies, and medicines of all types reach patients in need. Explore our holistic suite of solutions.
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world....
[sen-ˈkȯr -uh] noun. A leading global pharmaceutical solutions organization committed to improving the lives of people and animals everywhere. A company rooted in what is most important: keeping our customers, their patients, and our team members at the center of everything we do.
Aug 30, 2023 · CONSHOHOCKEN, Pa., August 30, 2023 -- ( BUSINESS WIRE )--Cencora, Inc. (NYSE: COR) today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation (NYSE:...
